Juno Therapeutics Plunges 30% After 2 Patient Deaths From Lead Cancer Drug
July 07, 2016 at 16:36 PM EDT
Juno Therapeutics Inc (NASDAQ: JUNO) was halted shortly after Thursday's closing bell. A couple minutes later, the company ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.